News

The Phase 2 study will enroll approximately 20 patients who will receive etirinotecan pegol once every three weeks as monotherapy. Stanford Cancer Institute professor of neurology and neurosurgery,

As a part of the collaboration, Gallus will provide process development and clinical and commercial supply for mammalian cell-based biopharmaceutical products to Theorem’s customers. Theorem will provide contract

The grant will allow analyzing the human genome comprehensively to find additional genetic predispositions to developing COPD in the COPDGene Study. The COPD Foundation president and co-founder John

Spring Point Project’s team has experience under the current Good Manufacturing Practices required by US Food and Drug Administration regulations. Islet Sciences chairman and CEO John Steel said

Under the license agreement, Pfizer will have the exclusive rights to market and sell EpiPen Injection 0.3/0.15mg in Japan, which is the only approved epinephrine auto-injector in the

Cellceutix chief scientific officer Krishna Menon said to date, everything is completed and Cellceutix is waiting for the host hospitals to begin dosing patients, which the company anticipates

The approved product is the generic version of Hospira’s Amidate injection, used as intravenous injection for the induction of general anesthesia. Mylan at present has 169 ANDAs pending

AC-201 is an orally available small molecule in development which modulates the intracellular synthesis of the cytokine IL-1Beta. TWi Pharmaceuticals acting president Calvin Chih-Kuang Chen said, "We are

Cinryze is a purified, pasteurized and nanofiltered plasma-derived C1 esterase inhibitor product for intravenous use. The company anticipates completion of labeling for previously produced vials to take approximately